Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cemindo Gemilang Tbk. (CMNT) vs Diagnos Laboratorium Utama Tbk. (DGNS) Price & Performance

Cemindo Gemilang Tbk.Trade
Diagnos Laboratorium Utama Tbk.Trade

Price performance (Past 24H)

Key statistics

Cemindo Gemilang Tbk. vs Diagnos Laboratorium Utama Tbk. — how do they compare? Cemindo Gemilang Tbk. trades at Rp795 (market cap 13.36T, 25.12M 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume). The key difference: Cemindo Gemilang Tbk. is far larger — about 42.2× Diagnos Laboratorium Utama Tbk.'s market cap, and Cemindo Gemilang Tbk. is more actively traded (25.12M versus 41.7K). Which is the better fit depends on your goals.

CMNTDGNS
Market Cap
13.36T316.25B
Volume
25.12M41.7K
Lot
251.24K417
Turnover
20.08B9.66M
Average Price
799.24231.65
Value
20.08B9.66M
Indicative Equilibrium Price
795230
Indicative Equilibrium Volume
5122.4K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CMNT
View details
DGNS
View details

About Cemindo Gemilang Tbk.

PT Cemindo Gemilang Tbk (the “Company”) was established in Indonesia based on Notarial Deed No. 9 of Humberg Lie, S.H., S.E., M.Kn, dated July 4, 2011.

Read more on CMNT

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS